chr18-77250584-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_001480.4(GALR1):āc.36C>Gā(p.Asn12Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,543,906 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001480.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALR1 | NM_001480.4 | c.36C>G | p.Asn12Lys | missense_variant | 1/3 | ENST00000299727.5 | |
LOC124904329 | XR_007066422.1 | n.604+264G>C | intron_variant, non_coding_transcript_variant | ||||
GALR1 | XM_017025691.2 | c.36C>G | p.Asn12Lys | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALR1 | ENST00000299727.5 | c.36C>G | p.Asn12Lys | missense_variant | 1/3 | 1 | NM_001480.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152186Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000214 AC: 31AN: 145058Hom.: 0 AF XY: 0.000240 AC XY: 19AN XY: 79208
GnomAD4 exome AF: 0.000176 AC: 245AN: 1391720Hom.: 1 Cov.: 37 AF XY: 0.000199 AC XY: 137AN XY: 687552
GnomAD4 genome AF: 0.000151 AC: 23AN: 152186Hom.: 0 Cov.: 34 AF XY: 0.0000942 AC XY: 7AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.36C>G (p.N12K) alteration is located in exon 1 (coding exon 1) of the GALR1 gene. This alteration results from a C to G substitution at nucleotide position 36, causing the asparagine (N) at amino acid position 12 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at